JOSEPH KHOURY to Safety
This is a "connection" page, showing publications JOSEPH KHOURY has written about Safety.
Connection Strength
0.054
-
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Lancet Haematol. 2018 Dec; 5(12):e618-e627.
Score: 0.035
-
Validation of a HOME Injury Survey. Inj Prev. 2009 Oct; 15(5):300-6.
Score: 0.019